Selecta Biosciences Inc

NASDAQ:SELB   11:26:56 AM EDT
0.73
+0.03 (+4.33%)
Earnings Announcements

Selecta Biosciences Reports First Quarter 2022 Financial Results

Published: 05/05/2022 11:48 GMT
Selecta Biosciences Inc (SELB) - Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update.
Selecta Had $118.8 Million in Cash, Cash Equivalents, Marketable Securities, and Restricted Cash As of March 31, 2022.
Qtrly Diluted Net Income per Share $0.08.
Qtrly Basic Net Income per Share $0.23.
Q1 Earnings per Share View $-0.11 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $18.03 Million
Adjusted EPS is expected to be -$0.05

Next Quarter Revenue Guidance is expected to be $13.4 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.